|
1
|
de Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
2
|
Hughes WT, Armstron D, Bodey GP, Bow EJ,
Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL and
Young LS: 2002 Guidelines for the use of antimicrobial agents in
neutropenic patients with cancer. Clin Infet dis. 34:730–751.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Solomayer EF, Feuerer M, Bai L, Umansky V,
Beckhove P, Meyberg GC, Bastert G, Schirrmacher V and Diel IJ:
Influence of adjuvant hormone therapy and chemotherapy on the
immune system analysed in the bone marrow of patients with breast
cancer. Clin Cancer Res. 9:174–180. 2003.PubMed/NCBI
|
|
4
|
Trueman P: Prophylactic G-CSF in patients
with early-stage breast cancer: A health economic review. Br J
Cancer. 101 (Suppl 1):S15–S17. 2009.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Zhang M, Liu X, Li J, He L and Tripathy D:
Chinese medicinal herbs to treat the side-effects of chemotherapy
in breast cancer patients. Cochrane Database Syst Rev.
2(CD004921)2007.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Taixiang W, Munro AJ and Guanjian L:
Chinese medical herbs for chemotherapy side effects in colorectal
cancer patients. Cochrane Database Syst Rev.
1(CD004540)2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen S, Flower A, Ritchie A, Liu J,
Molassiotis A, Yu H and Lewith G: Oral Chinese herbal medicine
(CHM) as an adjuvant treatment during chemotherapy for non-small
cell lung cancer: A systematic review. Lung Cancer. 68:137–145.
2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Yaal-Hahoshen N, Maimon Y,
Siegelmann-Danieli N, Lev-Ari S, Ron IG, Sperber F, Samuels N,
Shoham J and Merimsky O: A prospective, controlled study of the
botanical compound mixture LCS101 for chemotherapy-induced
hematological complications in breast cancer. Oncologist.
16:1197–1202. 2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cohen Z, Maimon Y, Yoeli-Lerner M, Yang P,
Samuels N and Berger R: Selective anticancer effects and protection
from chemotherapy by the botanical compound LCS101: Implications
for cancer treatment. Int J Oncol. 46:308–316. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rachmut IH, Samuels N, Melnick SJ,
Ramachandran C, Sharabi Y, Pavlovsky A, Maimon Y and Shoham J:
Immunomodulatory effects of the botanical compound LCS101:
Implications for cancer treatment. Onco Targets Ther. 6:437–445.
2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Crawford J, Dale DC and Lyman GH:
Chemotherapy-induced neutropenia: Risks, consequences, and new
directions for its management. Cancer. 100:228–237. 2004.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bodey GP, Buckley M, Sathe YS and
Freireich EJ: Quantitative relationships between circulating
leukocytes and infection in patients with acute leukemia. Ann
Intern Med. 64:328–340. 1966.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Crawford J: Prevention and treatment of
chemotherapy-induced neutropenia. Clin Adv Hematol Oncol.
11:514–517. 2013.PubMed/NCBI
|
|
14
|
Wang J, Tong X, Li P, Cao H and Su W:
Immuno-enhancement effects of Shenqi Fuzheng Injection on
cyclophosphamide-induced immunosuppression in Balb/c mice. J
Ethnopharmacol. 139:788–795. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen X, Zhang L and Cheung PC:
Immunopotentiation and anti-tumor activity of
carboxymethylated-sulfated β-(1→3)-D-glucan from Poria
cocos. Int Immunopharmacol. 10:398–405. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Smiderle FR, Baggio CH, Borato DG,
Santana-Filho AP, Sassaki GL, Iacomini M and Van Griensven LJ:
Anti-inflammatory properties of the medicinal mushroom Cordyceps
militaris might be related to its linear (1→3)-β-D-glucan. PLoS
One. 9(e110266)2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bone K and Mills S: Principles and
Practice of Phytotherapy. 2nd edition. Churchill Livingstone,
Edinburgh, 2000.
|
|
18
|
Zhao XZ: Effects of Astragalus
membranaceus and Tripterygium hypoglancum on natural
killer cell activity of peripheral blood mononuclear in systemic
lupus erythematosus. Zhongguo Zhong Xi Yi Jie He Za Zhi.
12:669–671, 645. 1992.PubMed/NCBI(In Chinese).
|
|
19
|
Zhu JS, Halpern GM and Jones K: The
scientific rediscovery of a precious ancient Chinese herbal
regimen: Cordyceps sinensis: part II. J Altern Complement
Med. 4:429–457. 1998.PubMed/NCBI View Article : Google Scholar
|
